Status:
COMPLETED
Autonomic Assessment in Patients With Restless Legs Syndrome
Lead Sponsor:
Kocaeli Derince Education and Research Hospital
Conditions:
Restless Legs Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
Restless legs syndrome (RLS) is a sensorimotor, sleep-related disorder characterized by urgency to move the legs during inactivity or resting state. Although the exact mechanism is not clearly underst...
Detailed Description
Restless legs syndrome (RLS) also known as Willis- Ekbom disease, is a common sensorimotor, sleep-related disorder characterized by an unpleasant feeling with urgency to move the legs (or less commonl...
Eligibility Criteria
Inclusion
- For the patient group:
- age \>18, \<65
- newly diagnosed, drug naive patients with primary restless legs syndrome
- For the control group:
- age \>18, \<65
- participants without chronic systemic disorder
Exclusion
- previous diagnosis of primary RLS
- subjects with secondary RLS
- concomitant use of drugs that could interfere with autonomic nervous system
- individuals with a known acute/chronic medical disease
- individuals with a minimental test score \< 25/30
- sleep disorders that could affect test performances
Key Trial Info
Start Date :
November 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 12 2021
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT04906486
Start Date
November 12 2020
End Date
April 12 2021
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sehnaz Basaran
İzmit, Marmara, Turkey (Türkiye), 41900